The next focusIR Investor Webinar takes places on 14th May with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksScience Group Regulatory News (SAG)

Share Price Information for Science Group (SAG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 438.00
Bid: 430.00
Ask: 446.00
Change: 0.00 (0.00%)
Spread: 16.00 (3.721%)
Open: 438.00
High: 438.00
Low: 438.00
Prev. Close: 438.00
SAG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Investment in Frontier Smart Technologies Grp Ltd

14 Jun 2019 07:00

RNS Number : 1781C
Science Group PLC
14 June 2019
 

 

14 June 2019

 

Science Group plc

 

Investment in Frontier Smart Technologies Group Limited

("Frontier")

 

 

 

Science Group plc ("Science Group") currently holds a total of 11,510,521 ordinary shares in Frontier, equivalent to 28.3% per cent. of the voting share capital of Frontier.

 

Science Group has continued to try to engage with Frontier but no tangible progress has been made since the first letter on 8 May 2019. In the opinion of Science Group, Frontier has consistently tried to frustrate Science Group's proposal, most recently by the notification to Science Group that deal-related bonuses have been granted to the Executive Directors of Frontier, equivalent to 6 months' salary in addition to their contractual rights. Were Frontier subject to the UK City Code on Takeovers and Mergers (the "Code"), such changes to director terms of employment (which Science Group considers material in the context of a transaction of this size) could be deemed a frustrating action requiring approval of the Takeover Panel and the bidder. The Frontier Board's asserted application of the principles of the Code continues to be highly selective.

 

Disclosure of Inside Information

 

On 12 June 2019, following a conversation with N+1 Singer, adviser to Frontier, Panmure Gordon (UK) Limited ("Panmure Gordon", adviser to Science Group) informed Science Group that N+1 Singer had disclosed information in relation to Frontier which it considered to be inside information ("Information") to Panmure Gordon without Panmure Gordon's prior consent. Science Group elected not to receive the Information and declined to be made inside. For the avoidance of any doubt, Science Group has not received the Information.

 

Science Group has been advised that, if Frontier cannot ensure the confidentiality of the Information and the Information includes inside information, Frontier has a regulatory obligation to disclose the Information to the market immediately and has written to Frontier accordingly. (Science Group and its advisers are not subject to any non-disclosure or confidentiality agreements in regard to the discussions with Frontier.) Science Group has not received any substantive reply to this letter.

 

Given that Panmure Gordon became a non-consenting recipient of the Information disclosed by N+1 Singer, and Science Group declined to receive the Information, Panmure Gordon has regrettably had to resign as Financial Adviser and Broker to Science Group in connection with the proposed transaction. Panmure Gordon will continue as Nomad and Corporate Broker to Science Group.

 

Non-Applicability of UK Takeover Code

 

Science Group reiterates that Frontier is not subject to the Code as set out in the announcement on 20 May 2019. This means that, among other provisions within the Code that do not apply, Science Group is:

· not under an obligation to make a mandatory offer for all the shares of Frontier should its shareholding exceed 30%;

· permitted to make any offer, should an offer be made, on less favourable terms than have been or may be used to make purchases in the market;

· permitted to make different arrangements or offers with different shareholders; and

· not subject to share trading restrictions in the Code.

 

Science Group may or may not make further purchases of Frontier shares in the market and may or may not make an offer for Frontier. There is no certainty that an offer will be made by Science Group nor as to the terms of any such offer should one be made.

 

- Ends -

 

For further information:

Science Group plc

 

Martyn Ratcliffe, Chairman

Sarah Cole, Company Secretary

Tel: +44 (0) 1223 875 200

 

Panmure Gordon (UK) Limited

Dominic Morley / Alina Vaskina (Nominated Adviser)

Erik Anderson (Corporate Broking)

 

 

Tel: +44 (0) 20 7886 2500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
MSCDGGDLUDBBGCX
Date   Source Headline
2nd May 20247:00 amRNSIssue of share options & PDMR dealing
1st May 20247:00 amRNSTransaction in Own Shares & Total Voting Rights
30th Apr 20247:00 amRNSTransaction in Own Shares
29th Apr 20249:12 amRNSTransaction in Own Shares
22nd Apr 20247:00 amRNSTransaction in Own Shares
17th Apr 20247:00 amRNSTransaction in Own Shares
16th Apr 20247:00 amRNSTransaction in Own Shares
15th Apr 20247:00 amRNSTreasury shares issued
15th Apr 20247:00 amRNSTransaction in Own Shares
12th Apr 20247:00 amRNSTreasury shares issued & PDMR dealing
8th Apr 20247:00 amRNSTransaction in Own Shares
27th Mar 20247:00 amRNSTransaction in Own Shares
25th Mar 20247:00 amRNSTransaction in Own Shares
21st Mar 20247:00 amRNSAudited results for year ended 31 December 2023
19th Mar 20247:00 amRNSNotice of Preliminary Results
26th Jan 20247:00 amRNSRule 19.6(c) confirmation of post-offer intentions
22nd Dec 20237:00 amRNSRule 19.6(b) update to post-offer intentions
18th Dec 20237:00 amRNSTransaction in Own Shares
12th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
30th Nov 202312:00 pmRNSTransaction in Own Shares
30th Nov 20237:00 amRNSTransaction in Own Shares
29th Nov 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSTransaction in Own Shares
23rd Nov 20237:00 amRNSTransaction in Own Shares
22nd Nov 20237:00 amRNSTrading Update
13th Nov 20237:00 amRNSTransaction in Own Shares
10th Nov 20237:00 amRNSTransaction in Own Shares
9th Nov 20237:00 amRNSTransaction in Own Shares
8th Nov 20237:00 amRNSTransaction in Own Shares
6th Nov 20237:00 amRNSTransaction in Own Shares
1st Nov 20237:00 amRNSTotal Voting Rights
30th Oct 20237:00 amRNSTransaction in Own Shares
27th Oct 20233:57 pmRNSTreasury Stock
27th Oct 20237:00 amRNSTransaction in Own Shares
26th Oct 20237:00 amRNSTransaction in own shares
25th Oct 20237:00 amRNSTransaction in Own Shares
24th Oct 20237:00 amRNSTransaction in Own Shares
23rd Oct 20237:00 amRNSTransaction in Own Shares
20th Oct 20237:00 amRNSTransaction in Own Shares
16th Oct 20237:01 amRNSTransaction in Own Shares
16th Oct 20237:00 amRNSTreasury & EBT Shares Issued
13th Oct 20237:00 amRNSTransaction in Own Shares
12th Oct 20237:00 amRNSTransaction in Own Shares
10th Oct 20237:00 amRNSTransaction in Own Shares
5th Oct 20237:00 amRNSTransaction in Own Shares
4th Oct 20237:00 amRNSTransaction in Own Shares
2nd Oct 20237:00 amRNSTransaction in Own Shares
27th Sep 20237:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.